The Financial Times Stock Exchange 100 Index (FTSE 100), also known as the Footsie, is a market-capitalization-weighted index of the 100 largest companies listed on the London Stock Exchange (LSE). It is one of the most widely followed stock indices globally and is often used as a barometer of the health of the UK economy.
The FTSE 100 was launched in 1984 and has since become one of the most influential stock indices in the world. The index is reviewed quarterly, with companies added or removed based on their market capitalization.
The Footsie is made up of a wide range of companies from various sectors, including energy, financials, healthcare, and technology. Some of the largest companies listed on the FTSE 100 include BP, HSBC, AstraZeneca, and GlaxoSmithKline.
The FTSE 100 is a market-capitalization-weighted index. This means that the value of each company in the index is weighted by its market capitalization, which is the number of shares outstanding multiplied by the current share price. The total market capitalization of the 100 companies in the index is then divided by the FTSE 100 divisor to create the index value.
The FTSE 100 is an important indicator of the health of the UK economy. It is used by investors, analysts, and policymakers to assess the performance of the UK stock market and the broader economy. The index is also used as a benchmark for many investment funds and pension schemes.
There are several benefits to investing in the FTSE 100, including:
There are various strategies that investors can use to invest in the FTSE 100. These include:
Before investing in the FTSE 100, investors should consider the following factors:
Pros:
Cons:
If you are considering investing in the FTSE 100, it is important to do your research and consider your risk tolerance and investment horizon. You should also seek professional advice from a financial advisor.
Rank | Company | Market Capitalization (GBP billion) |
---|---|---|
1 | Shell | 189.4 |
2 | HSBC Holdings | 133.6 |
3 | BP | 96.5 |
4 | Unilever | 93.0 |
5 | AstraZeneca | 89.4 |
6 | GlaxoSmithKline | 75.9 |
7 | Rio Tinto Group | 73.5 |
8 | Diageo | 66.5 |
9 | Reckitt Benckiser | 65.8 |
10 | Vodafone Group | 62.9 |
Year | Return (%) |
---|---|
2013 | 14.4 |
2014 | 0.6 |
2015 | 0.9 |
2016 | -1.8 |
2017 | 21.8 |
2018 | -12.5 |
2019 | 12.0 |
2020 | -14.3 |
2021 | 14.3 |
2022 | -20.3 |
Year | Dividend Yield (%) |
---|---|
2013 | 3.7 |
2014 | 3.5 |
2015 | 3.4 |
2016 | 3.3 |
2017 | 3.2 |
2018 | 3.1 |
2019 | 3.0 |
2020 | 2.9 |
2021 | 2.8 |
2022 | 2.7 |
2024-08-01 02:38:21 UTC
2024-08-08 02:55:35 UTC
2024-08-07 02:55:36 UTC
2024-08-25 14:01:07 UTC
2024-08-25 14:01:51 UTC
2024-08-15 08:10:25 UTC
2024-08-12 08:10:05 UTC
2024-08-13 08:10:18 UTC
2024-08-01 02:37:48 UTC
2024-08-05 03:39:51 UTC
2024-09-23 03:26:49 UTC
2024-10-13 18:26:28 UTC
2024-10-19 01:33:05 UTC
2024-10-19 01:33:04 UTC
2024-10-19 01:33:04 UTC
2024-10-19 01:33:01 UTC
2024-10-19 01:33:00 UTC
2024-10-19 01:32:58 UTC
2024-10-19 01:32:58 UTC